Artemisia annua sublingual immunotherapy in pediatric patients with seasonal allergic rhinoconjunctivitis: Comparison to adult patients
For patients suffering from SARC, <i>Artemisia annua</i>-SLIT demonstrates significant therapeutic efficacy and an excellent safety profile. Notably, we have provided the first evidence that the efficacy of <i>Artemisia annua</i>-SLIT is consistent across both adult and pediatric populations.
Authors
- Lina Jia
- Jinfang Wang (ORCID: https://orcid.org/0000-0002-4236-2283)
- Zhi-Ying Zheng (ORCID: https://orcid.org/0000-0002-0311-7234)
- Huixuan Hu
- Min Zhang (ORCID: https://orcid.org/0000-0002-6474-9059)
- Ying Liu (ORCID: https://orcid.org/0000-0002-1207-8409)
- Nana Dong (ORCID: https://orcid.org/0000-0002-8549-0998)
- Yan Feng (ORCID: https://orcid.org/0000-0002-8195-2294)
- Yan Zhao
Institutions
- Shanxi Medical University (CN)
- First Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Asia Pacific Allergy
- Published
- 2025-03-17
- DOI
- https://doi.org/10.5415/apallergy.0000000000000197
- Citations
- 3
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 4.87